![](/img/cover-not-exists.png)
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies
DeAngelo, D J, Spencer, A, Bhalla, K N, Prince, H M, Fischer, T, Kindler, T, Giles, F J, Scott, J W, Parker, K, Liu, A, Woo, M, Atadja, P, Mishra, K K, Ottmann, O GVolume:
27
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2013.38
Date:
August, 2013
File:
PDF, 593 KB
english, 2013